Healthcare ETFs
PPH — VanEck Pharmaceutical ETF
VanEck · MVIS US Listed Pharmaceutical 25 · since 2011
Global large-cap pharma only, including European names like Novo and Roche.
- Expense ratio
- 0.36%
- AUM
- $700M
- Dividend yield
- 2.4%
- 1Y return
- +13.1%
- 3Y ann.
- +8.4%
- 5Y ann.
- +9.8%
- 10Y ann.
- —
- Since inception
- —
Top holdings
- Eli Lilly8.20%
- Johnson & Johnson7.40%
- AbbVie6.10%
- Novartis5.40%
- AstraZeneca5.10%
26 total holdings · 58.0% in the top 10